November 13th 2024
Pharma looks to take advantage of expanded access programs across Asia-Pacific region.
Europe's "Radical" Regulators Drawn Further into Pricing Debate
June 9th 2016Radicals who wield real power at the EMA have gone public with their thinking about the role of regulators in the economic aspects of medicines provision – despite the decades-old EU taboo about linking pricing with authorizations.